Viridian Therapeutics, Inc. (VRDN)
14.88
-0.32
(-2.07%)
USD |
NASDAQ |
Apr 15, 16:00
14.88
0.00 (0.00%)
After-Hours: 16:13
Viridian Therapeutics EPS Diluted (Quarterly) : -1.080 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | -0.1022 |
| Amgen, Inc. | 2.455 |
| Boston Scientific Corp. | 0.4493 |
| Plus Therapeutics, Inc. | -1.03 |
| Nutriband, Inc. | -0.3212 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -101.98M |
| Revenue (Quarterly) | 0.132M |
| Total Expenses (Quarterly) | 102.11M |
| Enterprise Value | 860.62M |
| Gross Profit Margin (Quarterly) | -142.4% |
| Profit Margin (Quarterly) | -77.26K% |
| Earnings Yield | -25.59% |
| Normalized Earnings Yield | -25.56 |